Skip to main content
Laboratorio Farmaceutico Erfo logo

Laboratorio Farmaceutico Erfo — Investor Relations & Filings

Ticker · ERFO ISIN · IT0005497885 LEI · 8945005CB564D0OBQQ85 XMIL Manufacturing
Open in API
Filings indexed 127 across all filing types
Latest filing 2025-08-02 Transaction in Own Shar…
Country IT Italy
Listing XMIL ERFO

About Laboratorio Farmaceutico Erfo

https://www.erfo.it/

Laboratorio Farmaceutico Erfo S.p.A. specializes in the formulation, production, and marketing of nutraceutical products and food supplements. The company operates a multi-brand wellness ecosystem through a network of specialized centers. Its primary brand, Diètnatural, provides nutritional path services across more than 120 locations. The portfolio also includes BodySano, which focuses on nutrition and advanced aesthetics in French-speaking markets, and Fit&Go, a network of over 100 high-tech and fast-fitness centers. This integrated model combines the company's supplement products with personalized wellness, aesthetic, and fitness services delivered through its franchise networks.

Recent filings

Filing Released Lang Actions
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a press release from Laboratorio Farmaceutico Erfo S.p.A. detailing the weekly purchase of its own shares (buyback) as part of an authorized plan. It provides specific data on the number of shares purchased, the average price, and the total value for the period of July 28 to August 1, 2025. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2025-08-02 Italian
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a press release from Laboratorio Farmaceutico Erfo S.p.A. titled 'Informativa settimanale in merito al piano di acquisto azioni proprie' (Weekly report regarding the share buyback plan). It details the number of shares purchased, the average price, and the total value of the transactions for the week of July 21-25, 2025. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-07-25 Italian
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE IN MERITO AL PIANO DI ACQUISTO AZIONI PROPRIE" (Weekly Information Regarding the Own Share Purchase Plan). It details the number of shares purchased by Laboratorio Farmaceutico Erfo S.p.A. during the week of July 14 to July 18, 2025, as part of its buyback program. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS.
2025-07-18 Italian
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE IN MERITO AL PIANO DI ACQUISTO AZIONI PROPRIE" (Weekly Information Regarding the Share Buyback Plan) and details the number of shares purchased by Laboratorio Farmaceutico Erfo S.p.A. during the week of July 7 to July 11, 2025. This explicitly reports on the company's transaction in its own shares (buyback program). This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). Although it is a regulatory filing (indicated by 'Informazione Regolamentata'), the specific nature of the content points precisely to POS, which takes precedence over the general RNS category.
2025-07-12 Italian
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE IN MERITO AL PIANO DI ACQUISTO AZIONI PROPRIE" (Weekly Information Regarding the Share Buyback Plan). It details the number of shares purchased, the average price, and the total consideration for the week of June 30 to July 4, 2025. This activity directly relates to the company buying back its own shares. According to the definitions, the category for reporting the company buying back or selling its own shares is 'Transaction in Own Shares' (POS). The document is a formal announcement (Comunicato Stampa) detailing these transactions, not just an announcement that a report is forthcoming (which would suggest RPA or RNS).
2025-07-04 Italian
Comunicazione internal dealing
Director's Dealing Classification · 99% confidence The document is titled 'Modello di notifica e di comunicazione al pubblico delle operazioni effettuate da persone che esercitano funzioni di amministrazione, di controllo o di direzione e da persone a loro strettamente associate' (Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). The 'Oggetto' (Subject) is 'Comunicazione internal dealing'. This clearly indicates a report detailing personal share transactions by company directors or executives (insider trades). This matches the definition for Director's Dealing (DIRS). Although the text mentions 'Vedi allegato' (See attachment), the document itself contains the structured notification template filled out, making it the primary filing, not just an announcement of a report.
2025-07-02 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.